{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:54:11Z","timestamp":1746186851458},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.eimc.2014.07.005","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T21:02:49Z","timestamp":1414011769000},"page":"294","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Is high-dose intravenous fosfomycin safe for the treatment of patients prone to heart failure?"],"prefix":"10.1016","volume":"33","author":[{"given":"Irene","family":"Ca\u00f1amares-Orbis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Tiago","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"L\u00f3pez-Medrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Maria","family":"Aguado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2014.07.005_bib0005","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2014.07.005_bib0010","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1517\/14656566.2014.876991","article-title":"New pharmacological treatments for methicillin-resistant Staphylococcus aureus infections","volume":"15","author":"Burke","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.eimc.2014.07.005_bib0015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ja.2012.62","article-title":"In vitro susceptibility of Staphylococcus aureus and Staphylococcus epidermidis isolated from prosthetic joint infections","volume":"65","author":"Molina-Manso","year":"2012","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.eimc.2014.07.005_bib0020","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1471-2334-11-152","article-title":"High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible Staphylococcus aureus: case report","volume":"11","author":"Chen","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.eimc.2014.07.005_bib0025","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1128\/AAC.06449-11","article-title":"High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis","volume":"56","author":"Mir\u00f3","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2014.07.005_bib0030","unstructured":"ClinicalTrials.gov identifier: NCT01898338. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01898338?term=BACSARM&rank=1 [accessed 24.02.14]."},{"key":"10.1016\/j.eimc.2014.07.005_bib0035","unstructured":"Spanish agency for medicines and health products. Available at: http:\/\/www.ern.es\/wp-content\/uploads\/2013\/01\/FT-Fosfocina-IV-IM.pdf [accessed 24.02.14]."},{"key":"10.1016\/j.eimc.2014.07.005_bib0040","unstructured":"U.S. Food and Drug Administration, FDA approved drug products. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/065386lbl.pdf [accessed 24.02.14]."},{"key":"10.1016\/j.eimc.2014.07.005_bib0045","first-page":"147","article-title":"Clinical significance of the sodium content of intravenous antibiotic therapy","volume":"38","author":"Larrod\u00e9 Leci\u00f1ena","year":"2014","journal-title":"Farm Hosp"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X14002857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X14002857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T05:21:02Z","timestamp":1538112062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X14002857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0213005X14002857"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2014.07.005","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is high-dose intravenous fosfomycin safe for the treatment of patients prone to heart failure?","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2014.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Espa\u00f1a, S.L.U. y Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.","name":"copyright","label":"Copyright"}]}}